Autopsy report · NCT05032482

WeArable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease

“funding purposes”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Scion NeuroStim

Sponsor type

Industry

Conditions

Mild Alzheimer's Disease

Interventions

Non-invasive brainstem stimulation

Participants

0

Sites

5

Countries

United States

Trials that died the same way

• Cannabinoids for Taxane Induced Peripheral Neuropathy
  “Funding being sought” (79% match in meaning)
• Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis
  “Funding.” (77% match in meaning)
• Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy
  “Convenience of Government Funding Sponsor” (76% match in meaning)
• Amplification of Positivity for Alcohol Use Disorder Co-Occurring With Anxiety or Depression
  “Limited funding” (72% match in meaning)
• Community Hospital Identification of High CV Risk Patients During Cancer Treatment
  “Funding Issues” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.